Recombinant Staphylococcus aureus Ribosome-recycling factor (frr)

What is the molecular function of Ribosome-recycling factor in S. aureus?

Ribosome-recycling factor (RRF) in S. aureus is an essential translation factor that works synergistically with GTPase elongation factor G (EF-G) to split 100S ribosomes in a GTP-dependent manner. This process is critical for ribosome recycling after translation termination, allowing ribosomes to participate in new rounds of protein synthesis. The RRF/EF-G pair specifically targets post-termination 70S complexes and plays a vital role in reversing ribosome hibernation, which is linked to bacterial pathogenesis, persister formation, and stress responses .

What is the relationship between S. aureus RRF and ribosome hibernation?

S. aureus employs 100S ribosome formation (dimerization of 70S ribosomes) as a survival strategy during stress conditions. The RRF/EF-G pair is instrumental in reversing this hibernation state by splitting these 100S ribosomes, enabling the re-entry of individual ribosomes into the active translation pool. This reversal mechanism is particularly important during recovery from stress conditions and is directly linked to pathogenesis and persister cell formation .

What are optimal methods for expressing and purifying recombinant S. aureus RRF?

For high-yield expression of recombinant S. aureus RRF, an E. coli BL21(DE3) system with pET-based vectors containing the S. aureus frr gene is recommended. Expression should be induced with 0.5-1.0 mM IPTG at 30°C for 4 hours to minimize inclusion body formation. Purification typically employs a combination of affinity chromatography (using His-tagged constructs) followed by ion-exchange chromatography and size-exclusion chromatography to achieve >95% purity.

For functional studies, it's critical to verify that the recombinant protein maintains native conformation, which can be assessed through circular dichroism spectroscopy and activity assays measuring GTP hydrolysis in the presence of EF-G and ribosomes .

How can researchers effectively measure the GTP-dependent splitting of 100S ribosomes by RRF and EF-G?

To assess 100S ribosome splitting activity:

The activity is GTP-dependent but tRNA translocation-independent, so negative controls should include non-hydrolyzable GTP analogs to confirm specificity. RNase A treatment (5 μg/ml) can be used as a control to collapse polysomes and 100S complexes. Interestingly, some polysomes in RRF-depleted cells show resistance to 4x access of RNase A and preserve a disome-like fraction, which provides an additional experimental readout .

What structural techniques provide the most detailed insights into S. aureus RRF interactions with the ribosome?

Cryo-electron microscopy (cryo-EM) has emerged as the method of choice for studying S. aureus ribosomal complexes at high resolution. Recent advances have achieved resolutions of 2.0-3.1 Å for S. aureus ribosome complexes, allowing detailed visualization of factor binding and conformational changes .

For studying RRF specifically:

• Assemble a minimal high-occupancy complex containing S. aureus 70S ribosomes, synthetic mRNA, tRNA, and recombinant RRF

• Apply vitrification and imaging using state-of-the-art cryo-EM equipment

• Perform image processing using software like cryoSPARC to generate reconstructions

• Analyze both post-translocational state (POST) and chimeric hybrid state (CHI) conformations

This approach can reveal the molecular details of RRF binding and action on the ribosome, similar to how recent studies have elucidated antibiotic binding mechanisms to the S. aureus ribosome at resolutions reaching 2.0 Å .

How does the synergistic action between RRF and EF-G occur at the molecular level?

The synergistic action between RRF and EF-G in S. aureus involves a GTP-dependent but tRNA translocation-independent mechanism. At the molecular level, this process likely involves:

• Initial binding of RRF to the post-termination ribosome, positioning it in the A site

• Subsequent binding of EF-G·GTP, which induces conformational changes

• GTP hydrolysis by EF-G, providing the energy for ribosomal subunit dissociation

• Release of mRNA and deacylated tRNA from the ribosome

This mechanism is distinct from the canonical translocation activity of EF-G during elongation. The fact that this activity is translocation-independent indicates a specialized function of EF-G when working with RRF that differs from its role in the elongation cycle .

What is the competitive relationship between HflX and the RRF/EF-G pair in S. aureus ribosome recycling?

S. aureus employs two parallel pathways for ribosome recycling and hibernation reversal:

• The RRF/EF-G pathway: Primary under normal growth conditions

• The HflX pathway: Activated during heat stress conditions

These pathways are functionally interchangeable but differentially regulated. HflX is expressed at low levels and is largely dispensable under normal growth conditions, whereas the RRF/EF-G pair is constitutively essential. Cells lacking hflX do not accumulate 100S ribosomes unless subjected to heat stress, indicating that the RRF/EF-G pathway compensates under normal conditions .

This relationship represents a sophisticated regulatory system that ensures ribosome recycling continues under various stress conditions, contributing to S. aureus adaptability and pathogenesis.

How does RRF contribute to antibiotic resistance mechanisms in S. aureus?

RRF's role in ribosome recycling and hibernation reversal directly impacts antibiotic resistance through several mechanisms:

• Persister cell formation: By regulating ribosome hibernation, RRF influences the formation of persister cells that can survive antibiotic treatment

• Stress response modulation: RRF's function is intimately linked to stress responses, which often overlap with antibiotic resistance mechanisms

• Translation regulation: By ensuring efficient ribosome recycling, RRF helps maintain protein synthesis capacity during antibiotic stress

Additionally, mutations affecting the RRF/EF-G interaction could potentially contribute to resistance against antibiotics targeting protein synthesis. For instance, fusidic acid targets EF-G, and alterations in the RRF-EF-G interface might influence susceptibility to this antibiotic .

How can recombinant S. aureus RRF be utilized to screen for novel antimicrobial compounds?

Recombinant S. aureus RRF can be employed in high-throughput screening assays to identify potential inhibitors:

The optimal screening cascade would start with a biochemical assay measuring the GTP-dependent splitting of 100S ribosomes by RRF/EF-G, followed by cellular validation in S. aureus cultures. Compounds that specifically inhibit this activity without affecting general translation could represent a novel class of antibiotics with reduced likelihood of cross-resistance .

What methodological approaches can identify the binding interfaces between S. aureus RRF and the ribosome?

Several complementary techniques can elucidate the binding interfaces:

• Cryo-EM structure determination: Achieve high-resolution (2.0-3.1 Å) structures of S. aureus ribosome-RRF complexes, similar to the methodology used for antibiotic-bound ribosome structures

• Hydrogen-deuterium exchange mass spectrometry (HDX-MS): Identify regions of RRF and ribosomal proteins that show protection upon complex formation

• Cross-linking coupled with mass spectrometry (XL-MS): Use chemical cross-linkers to capture interaction points between RRF and ribosomal components

• Mutagenesis studies: Systematic alteration of residues at potential interfaces to identify those critical for binding and function

These approaches would generate a detailed map of interaction points that could serve as targets for structure-based drug design efforts .

How does inhibition of RRF affect S. aureus viability under different stress conditions?

Inhibition of RRF would have varying effects depending on the stress conditions:

• Under normal growth conditions: Severe impairment of growth due to accumulation of post-termination ribosomes and inefficient ribosome recycling

• Under nutrient limitation: Enhanced susceptibility due to inability to properly regulate ribosome hibernation and recycling

• Under heat stress: Potentially less severe impact due to the compensatory action of HflX, which can functionally replace RRF/EF-G during heat shock conditions

• During antibiotic exposure: Likely synergistic effects with antibiotics targeting translation, particularly those affecting termination or ribosome assembly

This variable response makes RRF an interesting target for combination antimicrobial therapies, where an RRF inhibitor could potentiate the effects of existing antibiotics, particularly against persister cells .

What are the key controls required when studying RRF-mediated ribosome recycling in vitro?

Critical controls for RRF studies include:

• GTP dependence: Parallel reactions with non-hydrolyzable GTP analogs (GMPPNP, GMPPCP) to confirm GTP hydrolysis requirement

• Factor specificity: Reactions with RRF alone, EF-G alone, and both together to demonstrate synergistic action

• RNase controls: Treatment with 5 μg/ml RNase A to differentiate genuine 100S ribosomes from polysomes

• Heat shock factor comparison: Parallel experiments with HflX to assess functional equivalence under different conditions

• Depletion verification: Immunoblotting to confirm RRF depletion in knockout or depletion studies

How can researchers distinguish between direct effects of RRF inhibition and secondary consequences in S. aureus?

To distinguish direct from indirect effects:

• Time-resolved studies: Monitor cellular changes at early timepoints after RRF inhibition/depletion before secondary effects manifest

• Complementation experiments: Express plasmid-encoded RRF resistant to the inhibition method to rescue direct effects

• Global analysis: Compare transcriptomics, proteomics, and ribosome profiling data from RRF-depleted cells and control cells

• Targeted metabolite analysis: Monitor specific markers of stress responses to identify primary and secondary metabolic consequences

• In vitro reconstitution: Verify that observed defects can be reproduced and rescued in a defined in vitro translation system

What are the most promising approaches to target S. aureus RRF for antimicrobial development?

The most promising approaches include:

• Structure-based drug design: Using high-resolution cryo-EM structures (similar to the 2.0-2.5 Å resolution achieved for ribosome-antibiotic complexes) to design small molecules that interfere with RRF binding or function

• Peptide mimetics: Developing peptides that mimic the binding interface between RRF and the ribosome or between RRF and EF-G

• Allosteric modulators: Identifying compounds that bind to allosteric sites on RRF, altering its conformation and impairing function

• Dual-targeting strategies: Developing compounds that simultaneously target RRF and EF-G interaction, potentially overcoming resistance mechanisms

The GTP-dependent but tRNA translocation-independent nature of the RRF/EF-G ribosome recycling mechanism offers unique targeting opportunities distinct from those exploited by current translation-targeting antibiotics .

How might the understanding of RRF function contribute to developing strategies against persistent S. aureus infections?

Understanding RRF function could address persistent infections through:

• Targeting hibernation reversal: Inhibiting RRF could prevent exit from the hibernation state, keeping bacteria dormant and potentially more susceptible to host immune clearance

• Persister-specific targeting: As RRF is involved in processes linked to persister formation, targeting it might specifically affect this antibiotic-tolerant subpopulation

• Stress response modulation: RRF inhibitors could prevent adaptation to changing host environments during infection

• Combinatorial approaches: Using RRF inhibitors alongside conventional antibiotics could create synergistic effects that eliminate both actively growing and persistent populations